WO2002102459A1 - Source de rayonnement therapeutique a entrainement optique - Google Patents

Source de rayonnement therapeutique a entrainement optique Download PDF

Info

Publication number
WO2002102459A1
WO2002102459A1 PCT/US2002/019416 US0219416W WO02102459A1 WO 2002102459 A1 WO2002102459 A1 WO 2002102459A1 US 0219416 W US0219416 W US 0219416W WO 02102459 A1 WO02102459 A1 WO 02102459A1
Authority
WO
WIPO (PCT)
Prior art keywords
electron
therapeutic radiation
source according
radiation source
optical
Prior art date
Application number
PCT/US2002/019416
Other languages
English (en)
Inventor
Mark Dinsmore
Original Assignee
Photoelectron Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/884,561 external-priority patent/US6480568B1/en
Priority claimed from US09/884,229 external-priority patent/US6493419B1/en
Application filed by Photoelectron Corporation filed Critical Photoelectron Corporation
Priority to JP2003505042A priority Critical patent/JP4268037B2/ja
Priority to EP02737538A priority patent/EP1409078A4/fr
Publication of WO2002102459A1 publication Critical patent/WO2002102459A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N5/1001—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
    • G—PHYSICS
    • G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
    • G21K—TECHNIQUES FOR HANDLING PARTICLES OR IONISING RADIATION NOT OTHERWISE PROVIDED FOR; IRRADIATION DEVICES; GAMMA RAY OR X-RAY MICROSCOPES
    • G21K1/00—Arrangements for handling particles or ionising radiation, e.g. focusing or moderating
    • G21K1/06—Arrangements for handling particles or ionising radiation, e.g. focusing or moderating using diffraction, refraction or reflection, e.g. monochromators
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01J—ELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS
    • H01J35/00—X-ray tubes
    • H01J35/32—Tubes wherein the X-rays are produced at or near the end of the tube or a part thereof which tube or part has a small cross-section to facilitate introduction into a small hole or cavity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N5/1001—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
    • A61N2005/1019—Sources therefor
    • A61N2005/1022—Generators, e.g. X-ray tubes
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01J—ELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS
    • H01J2235/00—X-ray tubes
    • H01J2235/16—Vessels
    • H01J2235/163—Vessels shaped for a particular application
    • H01J2235/164—Small cross-section, e.g. for entering in a body cavity
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01J—ELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS
    • H01J35/00—X-ray tubes
    • H01J35/02—Details
    • H01J35/04—Electrodes ; Mutual position thereof; Constructional adaptations therefor
    • H01J35/06—Cathodes
    • H01J35/064—Details of the emitter, e.g. material or structure

Definitions

  • the present invention relates to therapeutic radiation sources, and more particularly to a reduced power, increased efficiency miniaturized radiation source that utilizes an optically driven thermionic cathode.
  • therapeutic radiation such as x-ray radiation and ⁇ -ray radiation is used for diagnostic, therapeutic and palliative treatment of patients.
  • the conventional medical radiation sources used for these treatments include large, fixed position machines as well as small, transportable radiation generating probes.
  • the current state-of-the-art treatment systems utilize computers to generate complex treatment plans.
  • Conventional radiation systems used for medical treatment utilize a high power remote radiation source, and direct a beam of radiation at a target area, such as a tumor inside the body of a patient.
  • This type of treatment is referred to as teletherapy because the radiation source is located a predefined distance from the target.
  • This treatment suffers from the disadvantage that tissue disposed between the radiation source and the target is exposed to radiation.
  • Teletherapy radiation sources which apply radiation to target regions internal to a patient from a source external to the target regions, often cause significant damage not only to the target region or tissue, but also to all surrounding tissue between the entry site, the target region, and the exit site.
  • Brachytherapy is a form of treatment in which the source of radiation is located close to or in some cases within the area receiving treatment.
  • Brachytherapy a word derived from the ancient Greek word for close (“brachy"), offers a significant advantage over teletherapy, because the radiation is applied primarily to treat only a predefined tissue volume, without significantly affecting the tissue adjacent to the treated volume.
  • brachytherapy is commonly used to describe the use of a radioactive "seed,” i.e. encapsulated radioactive isotopes which can be placed directly within or adjacent the target tissue to be treated. Handling and disposal of such radioisotopes, however, may impose considerable hazards to both the handling personnel and the environment.
  • x-ray brachytherapy is defined for purposes of this application as x-ray radiation treatment in which the x-ray source is located close to or within the area receiving treatment.
  • An x-ray brachytherapy system which utilizes a miniaturized low power radiation source that can be inserted into, and activated from within, a patient's body, is disclosed in U.S. Patent No. 5,153,900 issued to Nomikos et al., U.S. Patent No. 5,369,679 to Sliski et al., and U.S. Patent No. 5,422,926 to Smith et al., all owned by the assignee of the present application, all of which are hereby incorporated by reference.
  • the x-ray brachytherapy system disclosed in the above-referenced patents includes a miniaturized, insertable probe which is capable of generating x-ray radiation local to the target tissue, so that radiation need not pass through the patient's skin, bone, or other tissue prior to reaching the target tissue.
  • the insertable probe emits low power x-rays from a nominal "point" source located within or adjacent to the desired region to be affected.
  • x-rays can be applied to treat a predefined tissue volume without significantly affecting the tissue adjacent to the treated volume.
  • x- rays may be produced in predefined dose geometries disposed about a predetermined location.
  • X-ray brachytherapy offers the advantages of brachytherapy, while avoiding the use and handling of radioisotopes.
  • x-ray brachytherapy allows the operator to control over time the dosage of the delivered x-ray radiation.
  • X-ray brachytherapy typically involves positioning the insertable probe into or adjacent to the tumor, or into the site where the tumor or a portion of the tumor was removed, to treat the tissue adjacent the site with a local boost of radiation.
  • X-ray probes of the type generally disclosed in U.S. Patent No. 5,153,900 include a housing, and a hollow, tubular probe or catheter extending from the housing along an axis and having an x-ray emitting target at its distal end.
  • the probe may enclose an electron source, such as a thermionic cathode.
  • an x-ray brachytherapy device as disclosed in U.S. Patent No.
  • an x-ray probe may include a flexible probe, such as a flexible fiber optic cable enclosed within a metallic sheath.
  • the x-ray probe may also include a substantially rigid capsule that is coupled to a distal end of the flexible probe.
  • the capsule encloses an electron source and an x-ray emissive target element.
  • the electron source may be a photocathode. In a photocathode configuration, a photoemissive substance is irradiated by a LED or a laser source, causing the generation of free electrons.
  • the flexible fiber optic cable couples light from a laser source or a LED to the photocathode.
  • an accelerating electric field may be established between the electron source and the target element.
  • the established electric field acts to accelerate the electrons emitted from the electron source toward the target element.
  • the target element emits radiation in response to incident electrons from the electron source.
  • a filament is heated resistively with a current. This in turn heats the cathode so that electrons are generated by thermionic emission.
  • the cathode assembly may consist of a thoriated tungsten coil approximately 2 mm in diameter and 1 to 2 cm in length. When resistively heated with a current of 4 A or higher, the thoriated tungsten coil thermionically emits electrons. In one configuration, this coil is surrounded by a metal focusing cup which concentrates the beam of electrons to a small spot on an opposing anode which also functions as the target.
  • the beam is focused on the anode to a spot diameter, usually ranging anywhere from about 0.3 to 2.5 millimeters.
  • a spot diameter usually ranging anywhere from about 0.3 to 2.5 millimeters.
  • most of the energy from the electron beam is converted into heat at the anode.
  • high power medical x-ray sources often utilize liquid cooling and a rapidly rotating anode.
  • An increased effective target area is thereby established, permitting a small focal spot while minimizing the effects of localized heating.
  • the anode typically is fabricated from copper.
  • the area of the anode onto which an electron beam is incident must be made from a material of high atomic number, in order for x-rays to be generated efficiently.
  • a tungsten alloy is typically embedded in the copper. It is desirable that the electron source be heated as efficiently as possible, namely that the thermionic cathode reach as high a temperature as possible using as little power as possible. In conventional x-ray tubes, for example, thermal vaporization of the tube's coiled cathode filament is frequently responsible for tube failure. Also, the anode heated to a high temperature can cause degradation of the radiation output. During relatively long exposures from an x-ray source, e.g. during exposures lasting from about 1 to about 3 seconds, the anode temperature may rise sufficiently to cause it to glow brightly, accompanied by localized surface melting and pitting which degrades the radiation output.
  • a photocathode avoids such problems
  • one disadvantage of using a photocathode is the difficulty in fabricating the photocathode.
  • a photocathode must have a sufficient quantum efficiency, where quantum efficiency relates to the number of electrons generated per incident light quantum. The degree of efficiency must be balanced to the intensity of available incident light.
  • the fab ⁇ cation of the photocathode should be performed in a vacuum.
  • the vacuum fabrication can be carried out with the fiber optic cable positioned in a bell jar.
  • an Ag-O-Cs photosurface can be fabricated in the conventional manner. Subsequently, without exposure to air, the fiber optic cable can be inserted into the tubular probe, and the end of the fiber optic cable can be vacuum sealed to the probe.
  • Heat loss in a laser-heated thermionic cathode includes 1) heat lost by thermal conduction; 2) heat loss caused by the portion of the incident laser radiation that remains unabsorbed; and 3) heat loss by thermal radiation.
  • the electron source and the target element are enclosed within a substantially rigid capsule.
  • the electron source generates an electron beam along a beam path, and the target element is positioned in the beam path.
  • An accelerating electric field may be established within the capsule. The accelerating electric field acts to accelerate the electrons emitted from the electron source toward the target element.
  • the target element emits therapeutic radiation in response to incident electrons from the electron source.
  • the capsule defines a substantially evacuated interior region extending along the electron beam axis.
  • the inner surface of the capsule is lined with an electrical insulator.
  • the vacuum is used extensively for the insulation of high voltages in devices such as the x-ray probes described above, the reliability of the vacuum is limited by the operational risk of an unpredictable "sparking" or “arcing" between the electrodes, when the insulating capability of the vacuum gap is suddenly lost and electrical breakdown is said to have occurred.
  • the efficient production of x-rays requires that the electron path be directly from the cathode to the target. If the electrons are deflected to the walls by effects of insulator charging, the efficiency of x-ray production is reduced, and stability of the x-ray output is compromised.
  • the present invention is directed to a miniaturized source of therapeutic radiation having a low power, electron-beam activated radiation source.
  • the apparatus of the present invention includes a thermionic cathode heated by a source of optical radiation, preferably a laser.
  • a therapeutic radiation source in accord with the present invention includes a radiation generator assembly, a source of optical radiation, and a probe assembly.
  • the source of optical radiation is preferably a laser that generates a substantially monochromatic, coherent beam of radiation.
  • the radiation generator assembly includes an electron source for emitting electrons to generate an electron beam along a beam path along a nominally straight reference axis, and a target element positioned in the beam path.
  • the electron source is preferably an optically driven thermionic cathode having an electron emissive surface.
  • the optically-driven thermionic cathode is spiral- shaped. In this way, heat loss due to thermal conduction within the thermionic cathode is minimized.
  • the spiral-shaped thermionic cathode is preferably made of a spiral-shaped conductive element.
  • the spiral-shaped conductive element has a plurality of spaced apart turns, and defines an interstitial spacing between each successive turn of said conductive element. Because the spiral-shaped conductive element is enclosed within the substantially evacuated interior region, heat transfer across the interstitial spacing between each adjacent turn of the conductive element is essentially eliminated. By minimizing heat lost by thermal conduction, the efficiency of the miniaturized thermionic cathode is increased.
  • the target element includes means for emitting therapeutic radiation in response to incident accelerated electrons from said electron beam.
  • the target element is spaced apart from and opposite the electron emissive surface of the thermionic cathode.
  • the target element includes at least one radiation emissive element adapted to emit therapeutic radiation in response to incident accelerated electrons from the thermionic cathode.
  • the therapeutic radiation source also includes means for providing an accelerating voltage so as to establish an accelerating electric field which acts to accelerate electrons emitted from said electron source toward the target element.
  • the radiation generator assembly further includes a substantially rigid capsule which encloses the electron source and the target element.
  • the electron source is at its proximal end, and the target element is at its distal end.
  • the capsule defines a substantially evacuated interior region extending along the nominally straight beam axis, between the thermionic cathode at the proximal end of the capsule and a target element at the distal end of the capsule.
  • the capsule preferably includes a radiation transmissive region, which may be disposed at the distal end of the capsule.
  • the total resistance of the inner surface of the capsule is preferably high enough to limit dissipated power to less than 10 % total target power.
  • the inner surface of the evacuated capsule is coated with a weakly conductive or semiconductive coating to provide a substantially smooth voltage gradient within the capsule, between the preselected maximum value and the ground potential.
  • the weakly conductive or semiconductive coating applied to the inner surface of the capsule, is also adapted to reduce secondary emissions of electrons striking the coated inner surface of the capsule.
  • the weakly conductive or semiconductive coating is further adapted to reduce the electrical field in the vicinity of the triple junction point, thus reducing the possibility of electrical flashover the triple junction point of the thermionic cathode. Sufficient current is carried in the coating to prevent charge buildup from field emission, and subsequent avalanche and breakdown.
  • the probe assembly includes an optical delivery structure, preferably a fiber optic cable, having a proximal end and a distal end.
  • the distal end of the fiber optic cable is coupled to the radiation generator assembly.
  • the fiber optic cable transmits optical radiation, generated by the source and incident on the proximal end, to the distal end.
  • the fiber optic cable directs a beam of the transmitted optical radiation to impinge upon a surface of the thermionic cathode, wherein the beam of optical radiation has a power level sufficient to heat at least a portion of a surface of the thermionic cathode to an electron emitting temperature so as to cause thermionic emission of electrons from the surface.
  • the probe assembly includes a flexible metallic sheath enclosing the fiber optic cable.
  • the means for providing the accelerating voltage is a power supply having a first terminal and a second terminal, and having drive means for establishing an output voltage between the first terminal and the second terminal.
  • the power supply may be electrically coupled to the target element by way of the first and second terminals.
  • the first terminal of the power supply can be electrically coupled to the electron emissive surface of the thermionic cathode, and the second terminal electrically coupled to the target element, thereby establishing an electric field which accelerates electrons emitted from the thermionic cathode toward the target element.
  • the apparatus of the present invention includes one or more reflector elements disposed at predetermined locations along an inner surface of the housing. The reflector elements are operative to reflect incident laser radiation unabsorbed by the thermionic cathode back to the thermionic cathode, thereby increasing the efficiency of the therapeutic radiation source.
  • FIGURE 1 (a) is a diagrammatic perspective view of a therapeutic radiation source having a resistively heated thermionic cathode.
  • FIGURE 1 (b) is a schematic representation of a therapeutic radiation source having a resistively heated thermionic cathode.
  • FIGURE 2 is a schematic block diagram of an overview of a therapeutic radiation source constructed according to the present invention, and having a laser-heated thermionic cathode.
  • FIGURE 3 is a diagrammatic view of one embodiment of a source of therapeutic radiation constructed according to the present invention, illustrating a laser source, a probe assembly and a radiation generator assembly embodying the present invention.
  • FIGURE 4 is an enlarged diagrammatic view of one embodiment of a probe assembly and a radiation generator assembly, constructed according to the present invention.
  • FIGURE 5 is an enlarged view of one end of a radiation generator assembly embodying the present invention, illustrating an electron source having a laser-heated thermionic cathode.
  • FIGURE 6 is an enlarged view of one embodiment of an electron source embodying the present invention, illustrating reflector elements which reflect back to the laser-heated thermionic cathode laser radiation that was unabsorbed by the thermionic cathode.
  • FIGURE 7 shows an embodiment of the present invention in which the therapeutic radiation source includes a spiral-shaped, laser-heated thermionic cathode.
  • FIGURE 8 (a) shows a plane view spiral-shaped thermionic cathode, constructed in accordance with the present invention.
  • FIGURE 8 (b) shows a side view of a spiral-shaped thermionic cathode, constructed in accordance with the present invention.
  • FIGURE 9 provides an enlarged view of a radiation generator assembly, and the distal end of the probe assembly, constructed in accordance with one embodiment of the present invention in which a weakly conductive or semiconductive coating is applied to the inner surface of the rigid capsule that encloses the electron source and the target element.
  • FIGURE 10 (a) illustrates an enlarged view of the field lines for the voltage gradient within an evacuated capsule.
  • FIGURE 10 (b) illustrates the triple junction point of the thermionic cathode used in the present invention.
  • the present invention is directed to a miniaturized, low power therapeutic radiation source which can be used for diagnostic, therapeutic and palliative treatment of patients.
  • a laser is used to heat a thermionic cathode to an electron emitting temperature.
  • the power requirements for the therapeutic radiation source are significantly reduced, as compared to systems in which the thermionic cathode is resistively heated.
  • Therapeutic radiation generated by the apparatus of the present invention may include, but is not limited to, x-rays.
  • the apparatus may be fully or partially implanted into, or surface mounted onto a desired area of a host, so as to irradiate a pre-selected region with therapeutic radiation.
  • the apparatus of the present invention can operate at a relatively low voltage, for example in the range of approximately 10 keV to 90 keV, with electron currents for example in the range of from approximately 1 nA to about 1 ⁇ A.
  • FIGURE 1 (a) shows a therapeutic radiation source 10 that generates and delivers therapeutic radiation in the form of x-rays.
  • the miniaturized, low power x-ray source 10 shown in FIGURE 1 (a) is a prior art x-ray brachytherapy system having a thermionic cathode that is heated using conventional resistive heating.
  • a suitable system is described in detail for example in the above-referenced U.S. Pat. No. 5,153,900, entitled "Miniaturized Low Power X-Ray Source.”
  • the system includes a housing 12 and an elongated, cylindrical probe 14 extending from the housing along a reference axis 16 and having a target assembly 26 at its distal end.
  • the probe 14 may be flexible or rigid, and is integral with the housing 12.
  • the housing 12 encloses a high voltage power supply 12 A.
  • the probe 14 is a hollow tube, and encloses an electron source 20.
  • the electron source 20 includes a thermionic cathode 22 that may be driven by a floating low voltage power supply.
  • the electron source 20 may also include an annular focusing electrode 23, in which case the thermionic cathode 22 is located in proximity to the annular focusing electrode 23, which is typically at nearly the same potential as the cathode.
  • the probe 14 extends along the same axis as the cathode 22 and the focusing electrode 23.
  • the probe 14 may be a hollow evacuated cylinder made of a beryllium (Be) cap and molybdenum-rhenium (Mo-Re), molybdenum (Mo) or mu-metal body.
  • the length of the probe 14 may be determined in view of the body region to be treated.
  • the cylinder may be 15 cm in length, with an interior diameter of 4 mm, and an exterior diameter of 5 mm. Different geometries of the probe 14 may be used for different body regions.
  • the main body of the probe 14 can be made of a magnetically shielding material such as a mu-metal.
  • the probe 14 can be made of a non-magnetic metal, preferably having relatively high values for Young's modulus and elastic limit.
  • FIGURE 1 (b) is a schematic representation of the prior art x-ray source apparatus 10 shown in FIGURE 1 (a).
  • the housing 12 is represented as being divided into a first portion 12' and a second portion 12".
  • a rechargeable battery 12B Enclosed within the first housing portion 12' is a rechargeable battery 12B, a recharge network 12D for the battery, which is adapted for use with an external charger 50, and a telemetry network 12E, adapted to be responsive to an external telemetry device 52 to function.
  • the first housing portion 12' is coupled by suitable communication means to the second housing portion 12".
  • the second housing portion 12" includes a high voltage power supply 12 A, the controller 12C, and the probe 14, as well as an electron beam generator.
  • the electron beam generator includes a photocathode 22 driven by an associated light source driver 55 and diode laser 56 and associated lens assembly 58.
  • the laser 56 illuminates the photocathode 22, which in turn generates electrons which are then accelerated toward the anode 24.
  • the anode 24 attracts the electrons, then passes them through its central aperture toward the target assembly 26.
  • the microprocessor 12C controls the power supply 12A and the light source driver 55 to dynamically adjust the cathode voltage, the electron beam current, and temporal parameters, or to provide pre-selected voltage, beam current, and temporal parameters.
  • the external telemetry device 52 and telemetry network 12E may cooperate to permit external control, either dynamic or predetermined, over the power supply 12A and temporal parameters.
  • the housing 12" may not be implanted into a host, and only the probe 14 may extend into a patient's body.
  • the controller 12C may be used directly to control the operation of the apparatus, and there is no need for the network 12E.
  • the 26 is adapted to be adjacent to or within the region to be irradiated.
  • the proximity of the emissive element to the targeted region, e.g. the tumor eliminates the need for the high voltages of prior art machines, in order to achieve satisfactory x-ray penetration through the body wall to the tumor site.
  • the low voltage also concentrates the radiation in the targeted tumor, and limits the damage to surrounding tissue and surface skin at the point of penetration.
  • FIGURE 2 is a schematic block diagram of an overview of one embodiment of a therapeutic radiation source 100, constructed according to the present invention.
  • the therapeutic radiation source 100 includes a laser-heated thermionic cathode, in contrast to the prior art therapeutic radiation sources (shown in FIGURES 1 (a) and 1 (b)), which included a resistively heated thermionic cathode, or a photocathode. Heating the thermionic cathode 122 with a laser, instead of a current, significantly reduces the power requirements for a therapeutic radiation source 100 constructed in accordance with the present invention.
  • the therapeutic radiation source 100 includes a radiation generator assembly
  • the source 104 of optical radiation is a laser, so that the optical radiation generated by the source 104 is substantially monochromatic, and coherent.
  • the laser may be a diode laser, by way of example; however other lasers known in the art may be used, such as a Nd:YAG laser, a Nd: YVO 4 laser, or a molecular laser.
  • other sources of high intensity light may be used, such as LEDs (light emitting diodes).
  • the radiation generator assembly 101 includes an electron source 122, and a target element 128 that includes means for emitting therapeutic radiation in response to incident accelerated electrons.
  • the electron source 122 is a thermionic cathode 122.
  • the probe assembly 106 includes an optical delivery structure 113, such as a fiber optic cable. The optical delivery structure 113 directs a beam of laser radiation generated by the laser source 104 onto the thermionic cathode 122. The laser beam heats the thermionic cathode 122 so as to cause thermionic emission of electrons.
  • FIGURES 3 and 4 illustrate a diagrammatic view of one embodiment of the therapeutic radiation source 100 constructed according to the present invention.
  • the therapeutic radiation source 100 includes a laser source 104, a probe assembly 106, and a radiation generator assembly 101.
  • the radiation generator assembly 101 includes an electron source 122 that generates an electron beam along a beam path 109, and a target element 128 positioned in the beam path 109.
  • the therapeutic radiation source 100 also includes means for providing an accelerating voltage between the electron source 122 and the target element 128.
  • the means for providing the accelerating voltage is a high voltage power supply 112.
  • the probe assembly 106 couples the laser source 104 and the high voltage power supply 112 to the radiation generator assembly 101.
  • FIGURE 3 provides an overall view of the therapeutic radiation source 100
  • FIGURE 4 provides an enlarged view of 1) the radiation generator assembly 101, and 2) the distal end of the probe assembly 106.
  • the probe assembly 106 includes an optical delivery structure 113 having a proximal end 113A and a distal end 113B.
  • the optical delivery structure 113 is enclosed within a flexible, electrically conductive catheter 105.
  • the distal end 113B of the optical delivery structure 113 is affixed to the radiation generator assembly 101.
  • the optical delivery structure 113 is a flexible fiber optic cable, extending from the proximal end 113A to the distal end 113B.
  • the flexible catheter 105 that encloses the fiber optic cable 113 is a small-diameter, flexible, metallic sheath.
  • the fiber optic cable 113 includes an electrically conductive outer surface 200.
  • the outer surface of the fiber optic cable 113 may be made conductive by applying an electrically conductive coating.
  • the electrically conductive outer surface 200 of the fiber optic cable 113 provides a connection to the thermionic cathode 122 from the high voltage power supply 112.
  • the radiation generator assembly 101 also has an electrically conductive outer surface.
  • both the flexible metallic sheath 105 and the outer conductive surface of the radiation generator assembly 101 are set at ground potential, in order to reduce the shock hazard of the device.
  • the flexible sheath 105 couples a ground return from the target element 128 to the high voltage power supply 112, thereby establishing a high voltage field between the thermionic cathode 122 and the target element 128.
  • the fiber optic cable 113 may have a diameter of about 200 microns, and the flexible metallic sheath 105 may have a diameter of about 1.4 mm.
  • a layer 210 of dielectric material provides insulation between the outer surface of the fiber optic cable 113 and the inner surface of the metallic sheath 105.
  • the radiation generator assembly 101 includes the electron source 122, and the target element 128.
  • the radiation generator assembly 101 which can be for example about 0.5 to about 2 cm in length, extends from the distal end of the probe assembly 106 and includes a shell or capsule 130 which encloses the electron source 122 and the target element 128.
  • the capsule 130 is rigid in nature and generally cylindrical in shape.
  • the cylindrical capsule 130 enclosing the other elements of the radiation generator assembly 101 can be considered to provide a substantially rigid housing for the electron source 122 and the target element 128.
  • the electron source 122 and the target element 128 are disposed within the housing 130, with the electron source 122 disposed at a proximal end of the capsule 130, and the target element 128 disposed at a distal end of the capsule 130.
  • the capsule 130 defines a substantially evacuated interior region extending along the beam axis 109, between the electron source 122 at the proximal end of the capsule 130 and the target element 128 at the distal end of the capsule 130.
  • the inner surface of the radiation generator assembly 101 is lined with an electrical insulator or semiconductor, while the external surface of the assembly 101 is electrically conductive, as mentioned earlier. A low secondary emission, controlled sheet resistance semiconducting film maximizes the high voltage breakdown voltage of the system.
  • the radiation generator assembly 101 is hermetically sealed to the end of the probe assembly, and evacuated.
  • the entire probe assembly 106 is evacuated.
  • the electron source 122 is a thermionic cathode 122 having an electron emissive surface.
  • an annular focusing electrode may also be provided.
  • the thermionic cathode 122 may be located in close proximity to the annular focusing electrode, which may be at nearly the same potential as the cathode.
  • the means for establishing an accelerating electric field is the high voltage power supply 112.
  • the power supply 112 has a first terminal 112A and a second terminal 112B, and has drive means for establishing an output voltage between the first terminal 112A and the second terminal 112B.
  • the power supply 112 may be electrically coupled to the target element by way of the first and second terminals.
  • the first terminal 112A of the power supply 112 is electrically coupled to the electron emissive surface of the thermionic cathode 122, and the second terminal 112B is electrically coupled to the target element 128.
  • the high voltage power supply 112 provides a high potential difference across the conductive outer surface 200 of the fiber optic cable, and the metallic sheath 105, to establish an acceleration potential difference between the thermionic cathode 122 and the grounded target element 128.
  • the electron beam is preferably thin (e.g. 1 mm or less in diameter), and is established along a beam path 109 along a nominally straight reference axis that extends to the target element 128.
  • the target element 128 is positioned in the beam path 109.
  • the distance from the electron source 122 to the target element 128 is preferably less than 2 mm.
  • the high voltage power supply 112 preferably satisfies three criteria: 1) small in size; 2) high efficiency, so as to enable the use of battery power; and 3) independently variable x-ray tube voltage and current, so as to enable the unit to be programmed for specific applications.
  • the power supply 112 includes selectively operable control means, including means for selectively controlling the amplitude of the output voltage and the amplitude of the beam generator current.
  • a high-frequency, switch-mode power converter is preferably used to meet these requirements.
  • the most appropriate topology for generating low power and high voltage is a resonant voltage converter working in conjunction with a high voltage, Cockroft- Walton-type multiplier.
  • the target element 128 is preferably spaced apart from and opposite the electron emissive surface of the thermionic cathode 122, and has at least one radiation emissive material adapted to emit therapeutic radiation in response to incident accelerated electrons from the electron emissive surface of the thermionic cathode 122.
  • the emitted therapeutic radiation consist of x-rays, however it should be noted that the scope of this invention is not limited to x-rays, and other forms of therapeutic radiation may also be generated.
  • the target element 128 is a small beryllium (Be) substrate, coated on the side exposed to the incident electron beam with a thin film or layer of a high-Z, x-ray emissive element, such as tungsten (W), uranium (U) or gold (Au).
  • a high-Z, x-ray emissive element such as tungsten (W), uranium (U) or gold (Au).
  • W tungsten
  • U uranium
  • Au gold
  • the beryllium substrate is 0.5 mm thick.
  • the target element 128 may include a multiple layer film, where the differing layers may have different emission characteristics.
  • the first layer may have an emission versus energy peak at a relatively low energy
  • the second underlying layer may have an emission versus energy peak at a relatively high energy.
  • a low energy electron beam may be used to generate x-rays in the first layer, to achieve a first radiation characteristic, and high energy electrons may be used to penetrate through to the underlying layer, to achieve a second radiation characteristic.
  • a 0.5 mm wide electron beam may be emitted at the cathode and accelerated to 30 keV, with 0.1 eV transverse electron energies, and may arrive at the target element 128, with a beam diameter of less than 1 mm at the target element 128.
  • X-rays are generated in the target element 128 in accordance with pre-selected beam voltage, current, and target element composition. The x-rays thus generated pass through the beryllium substrate with minimized loss in energy.
  • the target substrate may be made of carbon, ceramic such as boron nitride, or other suitable material which permits x-rays to pass with a minimum loss of energy.
  • An optimal material for target substrate is carbon in its diamond form, since that material is an excellent heat conductor. Using these parameters, the resultant x-rays have sufficient energy to penetrate into soft tissues to a depth of a centimeter or more, the exact depth dependent upon the x-ray energy distribution.
  • the target may be a solid, high-Z material, with x-rays being emitted in an annular beam perpendicular to the tube axis.
  • the probe assembly 106 along with its associated radiation generator assembly 101, can be coated with a biocompatible outer layer, such as titanium nitride on a sublayer of nickel.
  • a sheath of, for example, polyurethane can be fitted over the probe.
  • FIGURE 5 illustrates an electron source constructed according to the present invention, and including a laser-heated thermionic cathode 122.
  • the cathode disc can be held in place by means of swage of the end or by laser welding.
  • the thermionic cathode 122 has an electron emissive surface, and is typically formed of a metallic material. Suitable metallic materials forming the cathode 122 may include tungsten, thoriated tungsten, other tungsten alloys, thoriated rhenium, and tantalum.
  • the cathode 122 may be formed by depositing a layer of electron emissive material on a base material, so that an electron emissive surface is formed thereon.
  • the base material may be formed from one or more metallic materials, including but not limited to Group VI metals such as tungsten, and Group II metals such as barium.
  • the layer of electron emissive material may be formed from materials including, but not limited to, aluminum tungstate and scandium tungstate.
  • the thermionic cathode 122 may also be an oxide coated cathode, where a coating of the mixed oxides of barium and strontrium, by way of example, may be applied to a metallic base, such as nickel or a nickel alloy.
  • the metallic base may be made of other materials, including Group VI metals such as tungsten.
  • Getters 155 may be positioned within the housing 130.
  • the getters 155 aid in creating and maintaining a vacuum condition of high quality.
  • the getter has an activation temperature, after which it will react with stray gas molecules in the vacuum. It is desirable that the getter used have an activation temperature that is not so high that the x-ray device will be damaged when heated to the activation temperature.
  • the fiber optic cable 113 is adapted to transmit laser radiation, generated by the laser source 104 (shown in FIGURE 3) and incident on the proximal end 113A of the fiber optic cable 113, to the distal end 113B of the fiber optic cable 113.
  • the fiber optic cable 113 is also adapted to deliver a beam of the transmitted laser radiation to impinge upon the electron-emissive surface of the thermionic cathode 122.
  • the beam of laser radiation must have a power level sufficient to heat at least a portion of the electron-emissive surface to an electron emitting temperature so as to cause thermionic emission of electrons from the surface.
  • the laser beam shining down the fiber optic cable 113 impinges upon the surface of the thermionic cathode 122, and rapidly heats the surface to an electron emitting temperature, below the melting point of the metallic cathode 122.
  • electrons are thermionically emitted from the surface.
  • the high voltage field between the cathode 122 and the target element 128 (shown in FIGURES 3 and 4) accelerates these electrons, thereby forcing them to strike the surface of the target element 128 and produce x-rays.
  • a Nd:YAG laser was coupled into a SiO2 optical fiber having a diameter of 400 microns.
  • FIGURE 6 illustrates one embodiment of an electron source embodying the present invention, in which reflector elements 160 are included which reflect back to the thermionic cathode 122 incident laser radiation that was unabsorbed by the thermionic cathode 122.
  • FIGURE 6 shows an illustrative incident ray 152 of laser radiation which is unabsorbed and scattered by the thermionic cathode 122.
  • the scattered ray 153 of laser radiation impinges upon the inner surface of the capsule 130 enclosing the radiation generator assembly 101.
  • reflector elements 160 By placing reflector elements 160 at predetermined locations along the inner surface of the capsule 130, incident laser radiation that remained unabsorbed by the electron emissive surface of the thermionic cathode 122 is reflected back by the reflector elements 160 to the thermionic cathode 122, so that an optical cavity is effectively created within the capsule.
  • the coupling efficiency of the incident laser radiation to the thermionic cathode 122 is thereby significantly increased.
  • FIGURE 7 shows an embodiment of the present invention in which the therapeutic radiation source includes a spiral- shaped, laser-heated thermionic cathode 222.
  • a capsule 230 defines a substantially evacuated region extending along a beam axis 209, between the cathode 222 at the proximal end of the capsule 230 and a target element 228 at the distal end of the capsule 230, and incident laser light is transmitted through a fiber optical cable 213.
  • the spiral-shaped thermionic cathode 222 preferably has a plurality of spaced apart turns, an interstitial spacing being defined between each successive turn. Heat loss in the cathode due to thermal conduction is minimized, due to the spiral-shaped configuration of the cathode.
  • the thermionic cathode 222 includes a spiral-shaped conductive element having a plurality of spaced apart turns that define an interstitial spacing between adjacent turns.
  • the conductive element may be a wire, by way of example.
  • the conductive element may also be a photochemically machined flat spiral of cathode material. The spiral arrangement of the wire results in a reduction of conductive heat loss in the cathode.
  • the percentage of incident radiation that is absorbed at an incident spot on the cathode is typically about 40 %. Of the 40 % absorbed, however, further losses are caused because of thermal conduction within the cathode. In the illustrated embodiment, heat loss through thermal conduction is minimized, because the cathode 222 is in the shape of a spiral coil having a plurality of spaced apart turns. Heat loss through thermal conduction is substantially reduced, as compared to heat conduction within a disk-shaped thermionic cathode, because no heat transfer occurs across the vacuum between adjacent, spaced apart turns of the conductive element forming the cathode.
  • FIGURES 8(a) and 8(b) illustrate in more detail a spiral-shaped cathode 300 constructed in accordance with the present invention.
  • FIGURE 8(a) illustrates a planar view of the spiral- shaped cathode 300
  • FIGURE 8(b) illustrates a side view.
  • the spiral-shaped cathode 300 may be fabricated by using photoetching techniques known in the art.
  • the spiral-shaped cathode 300 includes a conductive element 310 arranged in a spiral shape.
  • the material forming the spiral-shaped conductive element is preferably a high melting point metal adapted to withstand high temperature uses.
  • Suitable materials forming the cathode may include tungsten, thoriated tungsten, other tungsten alloys, tantalum, rhenium, thoriated rhenium, and molybdenum.
  • the spiral-shaped conductive element 310 forms a planar coil, although other forms of conductive coils may be used, such as helical coils. Spiral coils of various shapes can be used. For example, each of the plurality of spaced apart turns may have a substantially circular shape, when viewed from the longitudinal direction. Alternatively, the spiral coil may have other transverse sectional shapes, such as oval, square, or rectangular.
  • the spiral-shaped conductive element 310 has a plurality of spaced apart turns, which define an interstitial spacing 330 between each successive turn.
  • the conductive element 310 may have a length of about 2 mm to about 7 mm, although other dimensions are also within the scope of this invention.
  • the distance between adjacent turns of the conductive element 310 may be about 25 microns to about 50 microns, although other dimensions are also within the scope of this invention. Since the spiral-shaped cathode 300 is disposed within the vacuum within the capsule 230, heat transfer across the interstitial spacing 330 between adjacent turns of the conductive element 310 is essentially eliminated. In this way, heat loss in the thermionic cathode 300 that is caused by thermal conduction is substantially reduced.
  • the spiral-shaped thermionic cathode 300 was fabricated using a conductive wire 0.002 mm thick, and 7.4 mm long.
  • the conductive wire defined two spaced-apart turns.
  • the power loss caused by thermal conduction was only 0.126 Watts, as compared to planar, disk-shaped cathodes, in which the power loss due to thermal conduction was about 1.1 Watts.
  • the power loss caused by thermal radiation was about 140 mW.
  • FIGURE 9 provides an enlarged view of a radiation generator assembly, and the distal end of the probe assembly, constructed in accordance with one embodiment of the present invention in which a weakly conductive or semiconductive coating is applied to the inner surface of the rigid capsule that encloses the electron source and the target element.
  • a weakly conductive or semiconductive coating is applied to the inner surface of the rigid capsule that encloses the electron source and the target element.
  • an electron source 208 and a target element 228 are enclosed within an evacuated capsule 230.
  • the interior surface of the capsule is coated with a layer 207 of weakly conductive or semiconductive material.
  • the layer 207 or weakly conductive or semiconductive coating is adapted to provide a substantially smooth voltage gradient within the capsule.
  • the interior surface of the capsule 230 is typically lined with an electrical insulator.
  • the interior surface is coated with a layer 207 of semiconductive or weakly conductive coating.
  • the layer 207 of weakly conductive or semiconductive coating serves to prevent localized high electric field regions or "spikes" within the accelerating region inside the capsule 230, thereby substantially reducing the chances of electrical breakdown within the vacuum inside the capsule
  • the layer 207 of weakly conductive or semiconductive coating also substantially reduces the chances of the secondary emissions from electrons striking the inner wall of the capsule 230 from causing a avalanche that eventually leads to an electrical breakdown.
  • the coating also ensures that the electron beam is not deflected off the target by chargeup effects on the insulator wall.
  • the illustrated embodiment of the present invention features an optically-driven, high efficiency therapeutic radiation source that maintains a substantially uniform voltage gradient within the evacuated region between the electron source and the target.
  • the layer 207 of weakly conductive or semiconductive coating allows a substantially smooth voltage gradient to be maintained between a predetermined maximum value of the accelerating voltage and ground potential.
  • the layer 207 of weakly conductive or semiconductive coating also serves to screen the thermionic cathode's "triple junction point," i.e. the junction between the cathode, housing wall, and vacuum, from high electric fields, thus preventing electron field emission and subsequent high voltage breakdown.
  • FIGURE 10 (a) illustrates an enlarged view of the interior of the substantially rigid capsule 230 having a layer 207 of weakly conductive or semiconductive coating.
  • FIGURE 10 (a) illustrates the electromagnetic field lines 330 within the interior of the capsule 230, showing a substantially smooth voltage gradient across the evacuated region within the capsule.
  • the capsule 230 has an interior surface 310 that defines a hollow, evacuated region 312.
  • a high voltage power supply provides an accelerating voltage for accelerating the electrons emitted from the electron source toward the target element. Because it is safer to maintain the target element at ground potential, the thermionic cathode may be negatively biased, so that the target element is maintained at a net positive voltage with respect to the thermionic cathode.
  • the accelerating voltage has a predetermined maximum value, typically about 90 keV.
  • the hollow interior surface 310 is coated with a layer 207 of weakly conductive or semiconductive coating.
  • the weakly conductive or semiconductive coating allows for voltage gradient control within the evacuated region.
  • the weakly conductive or semiconductive coating 207 allows a substantially smooth voltage gradient to be maintained between the predetermined maximum value of the accelerating voltage, and the ground potential, as illustrated by the voltage gradient field lines 330 in FIGURE 10(a).
  • the coating 207 may be made of weakly conductive or semiconductive materials, including but not limited to chromium sesquioxide, vanadium pentoxide, or ion implanted metals such as platinum.
  • the high-resistance coating 207 which is weakly conductive or semiconductive, and which is applied to the interior surface 310 of the capsule 230 in the optically-driven, miniaturized therapeutic radiation source of the present invention, improves the ability of the therapeutic source 200 to withstand high acceleration voltages, without breakdown. It also greatly enhances the x-ray output and stability, as the efficiency in propagating the electrons to the target is greatly increased. This is in contrast to prior art devices, such as disclosed in U.S. Patent No. 5,428,658, and in contrast to the miniaturized, optically-driven therapeutic radiation sources that do not include such a coating. These devices contained a film of insulating material on the inner surface of the evacuated capsule, rather than a high resistance, semiconductive (or weakly conductive) coating, so that no control was possible over the voltage gradient within the evacuated region.
  • the reliability of the vacuum within the capsule 230 is limited by the operational risk of an unpredictable "sparking” or “arcing” between the electrodes, when the insulating capability of the evacuated region 312 is suddenly lost, and electrical breakdown is said to have occurred. Because of such practical limitation of the insulating capability of the vacuum, localized high voltage gradient regions or “spikes” may be caused. Such spikes may occur in the accelerating region within the evacuated capsule 230, as the emitted electrons are accelerated toward the target. In order to avoid such spikes in the electric field within the evacuated region 312, it is preferable that the inner surface 310 of the capsule 230 be lined with a weakly conductive or semiconductive material that can directly control the electric field.
  • the present invention provides such as low dielectric constant material in the form of the resistive layer 207 of weakly conductive or semiconductive coating.
  • the breakdown voltage depends on a number of parameters, including but not limited to electrode material and geometry, surface preparation and geometry, vacuum quality, and vacuum gap spacing.
  • the breakdown voltage is typically a function of the dielectric constant of the material forming the capsule 230. It is preferable that the material forming the capsule 230 have a high dielectric strength, in order to withstand a large electrical field without breakdown.
  • the dielectric strength of the capsule material which may be a ceramic by way of example, is at least 100 kV / mm.
  • the ceramic material that forms the capsule 230 may include, but is not limited to, glass, boron nitride, sapphire, fused silica, and diamond.
  • the layer 207 of weakly conductive or semiconductive coating also serves to reduce secondary emissions from the interior surface 310. Secondary emissions of electrons hitting the walls of the capsule enclosing the accelerating region may cause an avalanche, eventually leading to a breakdown. Such an avalanche is likely to happen when the inner surface 310 of the capsule 230 is lined with an insulator material, for example a material having a secondary emission coefficient > 3.
  • the semiconductive coating 207 which in one exemplary embodiment may have a secondary emission coefficient ⁇ 1 , serves to prevent such an avalanche. Also, charge-up, and subsequent electric field intensification and breakdown, are eliminated by draining the charge through the weakly conductive or semiconductive layer.
  • FIGURE 10 (b) illustrates the thermionic cathode's triple junction point 350.
  • the triple junction point 350 may be screened from the high electrical field between the target element and the cathode 222 by the weakly conductive or semiconductive coating, thereby substantially reducing the chances of electrical flashover.
  • the electric field within the evacuated accelerating region is controlled by a resistive, weakly conductive or semiconductive coating 207 on the inner surface of the capsule enclosing the x-ray generator assembly.
  • the weakly conductive or semiconductive coating 207 generates a controlled voltage gradient across the vacuum within the capsule 230.
  • the weakly conductive or semiconductive coating 207 is adapted to reduce the strength of the electric field near the triple junction point of the thermionic cathode, thereby reducing the chances of electrical flashover.
  • the weakly conductive or semiconductive coating 207 prevents the amplification of the secondary emissions of electrons that hit the inner wall of the capsule 230 by absorbing the emitted electrons, thereby preventing an avalanche of emissions that could lead to electrical breakdown. For these reasons, the chances for electrical flashover or electric breakdown within the evacuated capsule 230 is substantially reduced, thereby providing a significant advantage over optically driven therapeutic radiation sources in which the inner surface of the capsule 230 is lined with an insulator material.
  • the weakly conductive or semiconductive coating increases the x-ray production efficiency and stability by ensuring that the electrons emitted from the cathode proceed directly to the target, thereby maximizing the probability that they will hit the x-ray target, and maximizing the electrons' kinetic energy as they impact the target.
  • the present invention significantly reduces the power requirements for such miniaturized therapeutic radiation sources, by heating a thermionic cathode with laser energy, instead of resistively heating the thermionic cathode with a current.
  • the present invention also features the use of a spiral-shaped thermionic cathode, which is configured so as to minimize energy lost from the incident laser radiation due to thermal conduction within the thermionic cathode. In this way, the power requirements for generating therapeutic radiation in such miniaturized radiation sources are further reduced.
  • the present invention also features the use of a weakly conductive or semiconductive coating, applied on the inner surface of the evacuated capsule.
  • a substantially uniform voltage gradient is established in the region between the electron source and the target, so that high electric field regions or spikes are avoided within the evacuated capsule, the chances of electrical breakdown are reduced, and the electrons propagate directly to the target.
  • the weakly conductive or semiconductive coating also reduces the chances for secondary emissions of electrons that strike the walls of the capsule to cause an avalanche that eventually causes an electrical breakdown. Field emitted currents are swept away, preventing charge-up and breakdown.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • General Engineering & Computer Science (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Radiation-Therapy Devices (AREA)
  • X-Ray Techniques (AREA)

Abstract

L'invention concerne une source miniature de rayonnement thérapeutique à entraînement optique (100) comprenant une cathode thermionique à tête laser (122). Un câble fibre optique (113) dirige un faisceau lumineux provenant d'une source optique (104) de manière qu'il se précipite sur une surface de la cathode thermionique (122), chauffant la surface à une température suffisante pour engendrer une émission thermionique d'électrons. L'élément cible (128) émet un rayonnement thérapeutique, tel que des rayons X, en réponse à des électrons accélérés incidents provenant du faisceau d'électrons. Dans un mode de réalisation, la source d'électrons (122) et l'élément cible (128) sont disposés dans une capsule (130) définissant une région sensiblement vide d'air. La surface interne de la capsule est revêtue d'un revêtement semi-conducteur, de manière à conserver un gradient de tension uniforme dans la capsule vide d'air. Dans un autre mode de réalisation, la cathode thermionique (300) est constituée d'un élément conducteur en forme de spirale (310) présentant une pluralité de tours espacés les uns des autres. Un espacement interstitiel entre des tours adjacents élimine sensiblement le transfert de chaleur dans l'espacement entre chaque tour adjacent.
PCT/US2002/019416 2001-06-19 2002-06-19 Source de rayonnement therapeutique a entrainement optique WO2002102459A1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2003505042A JP4268037B2 (ja) 2001-06-19 2002-06-19 光学的駆動式治療用放射線源
EP02737538A EP1409078A4 (fr) 2001-06-19 2002-06-19 Source de rayonnement therapeutique a entrainement optique

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US29920401P 2001-06-19 2001-06-19
US09/884,561 US6480568B1 (en) 2001-06-19 2001-06-19 Optically driven therapeutic radiation source
US09/884,229 US6493419B1 (en) 2001-06-19 2001-06-19 Optically driven therapeutic radiation source having a spiral-shaped thermionic cathode
US09/884,561 2001-06-19
US09/884,229 2001-06-19
US60/299,204 2001-06-19

Publications (1)

Publication Number Publication Date
WO2002102459A1 true WO2002102459A1 (fr) 2002-12-27

Family

ID=27404637

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/019416 WO2002102459A1 (fr) 2001-06-19 2002-06-19 Source de rayonnement therapeutique a entrainement optique

Country Status (4)

Country Link
EP (1) EP1409078A4 (fr)
JP (1) JP4268037B2 (fr)
CN (1) CN1596140A (fr)
WO (1) WO2002102459A1 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1494260A1 (fr) * 2003-06-30 2005-01-05 Nucletron B.V. Source à rayons x minaturisée
JP2006524881A (ja) * 2003-01-16 2006-11-02 カールツァイスシュティフトゥング、ディー／ビー／エイ カールツァイス、オーバーコーへン、ジャーマニー 熱的に調節される電界放出カソード及びビーム電流測定技術
GB2502109A (en) * 2012-05-16 2013-11-20 Ariane Medical Systems Ltd X-ray radiotherapy apparatus with indirectly heated emissive cathode

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6901136B1 (en) * 2003-12-02 2005-05-31 Ge Medical Systems Global Technology Co., Llc X-ray tube system and apparatus with conductive proximity between cathode and electromagnetic shield
JP2009021032A (ja) * 2007-07-10 2009-01-29 Takasago Thermal Eng Co Ltd Ｘ線発生管
US8437451B2 (en) * 2011-01-12 2013-05-07 Panalytical B.V. X-ray shutter arrangement
WO2013035823A1 (fr) * 2011-09-10 2013-03-14 株式会社Ｂｓｒ Appareil d'irradiation aux rayons x
CN105121845B (zh) * 2013-04-12 2018-12-28 维斯塔斯风力系统集团公司 涉及风力涡轮机传感器的改进
CN107432992B (zh) * 2016-05-26 2019-08-13 和鑫生技开发股份有限公司 近端治疗装置及其放射源
CN109892018B (zh) * 2016-10-31 2023-06-09 佳能安内华股份有限公司 X射线产生装置和x射线拍摄系统
WO2018119513A1 (fr) * 2016-12-29 2018-07-05 The University Of British Columbia Dispositif à faisceau d'électrons thermionique à adressage optique
JP7170979B2 (ja) * 2017-03-31 2022-11-15 エンピリアン メディカル システムズ，インコーポレイテッド ３次元ビームを形成するｘ線源
CN108395280B (zh) * 2018-03-21 2020-10-09 黄石上方检测设备有限公司 一种陶瓷x射线管内表面涂层组合物及其烧结方法
CN109199628B (zh) * 2018-10-30 2021-04-02 深圳先进技术研究院 一种生物组织光刺激装置
CN118647437A (zh) * 2022-03-08 2024-09-13 株式会社Dr-Cocos 光线治疗器及电极棒

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5153900A (en) 1990-09-05 1992-10-06 Photoelectron Corporation Miniaturized low power x-ray source
US5369679A (en) 1990-09-05 1994-11-29 Photoelectron Corporation Low power x-ray source with implantable probe for treatment of brain tumors
US5422926A (en) 1990-09-05 1995-06-06 Photoelectron Corporation X-ray source with shaped radiation pattern
US5504799A (en) * 1993-06-18 1996-04-02 Hamamatsu Photonics K.K. X-ray generation tube for ionizing ambient atmosphere
US6148061A (en) * 1997-04-28 2000-11-14 Newton Scientific, Inc. Miniature x-ray unit
US6320935B1 (en) * 2000-02-28 2001-11-20 X-Technologies, Ltd. Dosimeter for a miniature energy transducer for emitting X-ray radiation
US6324257B1 (en) * 1998-06-04 2001-11-27 X-Technologies Inc. Radiotherapeutical device and use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5568056A (en) * 1978-11-17 1980-05-22 Hitachi Ltd X-ray tube
EP0770258B1 (fr) * 1994-07-12 2001-10-24 Photoelectron Corporation Appareil a rayons x appliquant un flux predetermine sur une surface interne d'une cavite du corps
US6195411B1 (en) * 1999-05-13 2001-02-27 Photoelectron Corporation Miniature x-ray source with flexible probe

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5153900A (en) 1990-09-05 1992-10-06 Photoelectron Corporation Miniaturized low power x-ray source
US5369679A (en) 1990-09-05 1994-11-29 Photoelectron Corporation Low power x-ray source with implantable probe for treatment of brain tumors
US5422926A (en) 1990-09-05 1995-06-06 Photoelectron Corporation X-ray source with shaped radiation pattern
US5504799A (en) * 1993-06-18 1996-04-02 Hamamatsu Photonics K.K. X-ray generation tube for ionizing ambient atmosphere
US5428658A (en) 1994-01-21 1995-06-27 Photoelectron Corporation X-ray source with flexible probe
US6148061A (en) * 1997-04-28 2000-11-14 Newton Scientific, Inc. Miniature x-ray unit
US6324257B1 (en) * 1998-06-04 2001-11-27 X-Technologies Inc. Radiotherapeutical device and use thereof
US6320935B1 (en) * 2000-02-28 2001-11-20 X-Technologies, Ltd. Dosimeter for a miniature energy transducer for emitting X-ray radiation

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP1409078A4

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006524881A (ja) * 2003-01-16 2006-11-02 カールツァイスシュティフトゥング、ディー／ビー／エイ カールツァイス、オーバーコーへン、ジャーマニー 熱的に調節される電界放出カソード及びビーム電流測定技術
EP1494260A1 (fr) * 2003-06-30 2005-01-05 Nucletron B.V. Source à rayons x minaturisée
US7016471B2 (en) 2003-06-30 2006-03-21 Nucletron B.V. Miniature X-ray source device
AU2004202248B2 (en) * 2003-06-30 2008-05-01 Nucletron B.V. Miniature X-ray source device
GB2502109A (en) * 2012-05-16 2013-11-20 Ariane Medical Systems Ltd X-ray radiotherapy apparatus with indirectly heated emissive cathode

Also Published As

Publication number Publication date
EP1409078A4 (fr) 2009-04-08
CN1596140A (zh) 2005-03-16
JP4268037B2 (ja) 2009-05-27
JP2005502160A (ja) 2005-01-20
EP1409078A1 (fr) 2004-04-21

Similar Documents

Publication Publication Date Title
AU684652B2 (en) X-ray apparatus for applying a predetermined flux to an interior surface of a body cavity
US6320932B2 (en) Miniature radiation source with flexible probe and laser driven thermionic emitter
EP0547139B1 (fr) Source de rayons x miniaturisee de faible puissance
JP4268037B2 (ja) 光学的駆動式治療用放射線源
US6556651B1 (en) Array of miniature radiation sources
WO2006065299A1 (fr) Catheter avec ensemble ballonnet gonflable et source de rayons x a activation optique
EP0630039B1 (fr) Tube à rayons X
US6480568B1 (en) Optically driven therapeutic radiation source
USRE41741E1 (en) Optically driven therapeutic radiation source having a spiral shaped thermionic cathode
US6721392B1 (en) Optically driven therapeutic radiation source including a non-planar target configuration
US7382857B2 (en) X-ray catheter assembly
US6658086B2 (en) Optically driven therapeutic radiation source with voltage gradient control
US6480573B1 (en) Therapeutic radiation source with increased cathode efficiency
KR101837599B1 (ko) 탄소나노튜브 기반의 x-선 튜브를 이용한 켈로이드 및 피부암 치료용 x-선 근접 치료 장치에 사용되는 초소형 x-선 튜브 시스템
KR101837593B1 (ko) 탄소나노튜브 기반의 x-선 튜브를 이용한 켈로이드 및 피부암 치료용 x-선 근접 치료 시스템
KR101971653B1 (ko) 환부 삽입용 x-선 튜브 시스템 및 이를 포함하는 x-선 근접 치료 시스템
WO2013171491A1 (fr) Appareil de radiothérapie

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2003505042

Country of ref document: JP

Ref document number: 028121317

Country of ref document: CN

WWE Wipo information: entry into national phase

Ref document number: 2002737538

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2002737538

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642